(ASML) ASML Holding - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0010273215
Lithography, Metrology, Inspection, Software, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.73% |
| Yield on Cost 5y | 1.73% |
| Yield CAGR 5y | 25.07% |
| Payout Consistency | 84.7% |
| Payout Ratio | 27.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 35.8% |
| Value at Risk 5%th | 53.7% |
| Relative Tail Risk | -8.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 23.55 |
| CAGR/Max DD | 0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 0.430 |
| Beta Downside | 0.548 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.77% |
| Mean DD | 16.89% |
| Median DD | 12.10% |
Description: ASML ASML Holding December 11, 2025
ASML Holding N.V. designs, manufactures, and services lithography equipment that patterns silicon wafers for semiconductor fabs. Its portfolio spans extreme-ultraviolet (EUV) systems, deep-ultraviolet (DUV) immersion and dry tools, metrology/inspection solutions (e.g., YieldStar and HMI electron-beam), and computational lithography software, plus aftermarket upgrades and customer support.
In FY 2023 the company reported €21.2 billion in revenue, with a gross margin of roughly 48 % and an R&D intensity near 24 % of sales, reflecting the capital-intensive nature of EUV development. The order backlog-about €30 billion at year-end-provides visibility into demand for next-generation nodes (7 nm and below).
ASML’s growth is tightly linked to macro drivers such as the global shift toward AI-enabled data centers, 5G infrastructure, and automotive electrification, all of which increase demand for smaller, more power-efficient chips. A critical sector constraint is the limited number of EUV suppliers; ASML’s near-monopoly in high-NA EUV positions it as a bottleneck-free source of capacity, but also subjects it to geopolitical risk in its key markets (China, Taiwan, South Korea).
For a deeper dive into valuation metrics and scenario analysis, you may find the ASML page on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (9.46b TTM) > 0 and > 6% of Revenue (6% = 1.93b TTM) |
| FCFTA 0.20 (>2.0%) and ΔFCFTA 13.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.38% (prev 33.69%; Δ -15.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 10.79b > Net Income 9.46b (YES >=105%, WARN >=100%) |
| Net Debt (-8.05b) to EBITDA (9.57b) ratio: -0.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (388.1m) change vs 12m ago -1.39% (target <= -2.0% for YES) |
| Gross Margin 52.71% (prev 51.15%; Δ 1.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 74.17% (prev 62.82%; Δ 11.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 57.50 (EBITDA TTM 9.57b / Interest Expense TTM 153.7m) >= 6 (WARN >= 3) |
Altman Z'' 3.87
| (A) 0.13 = (Total Current Assets 25.15b - Total Current Liabilities 19.22b) / Total Assets 45.10b |
| (B) 0.32 = Retained Earnings (Balance) 14.41b / Total Assets 45.10b |
| (C) 0.20 = EBIT TTM 8.84b / Avg Total Assets 43.43b |
| (D) 0.57 = Book Value of Equity 14.90b / Total Liabilities 26.10b |
| Total Rating: 3.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 90.65
| 1. Piotroski 9.0pt |
| 2. FCF Yield 2.56% |
| 3. FCF Margin 27.76% |
| 4. Debt/Equity 0.25 |
| 5. Debt/Ebitda -0.84 |
| 6. ROIC - WACC (= 79.89)% |
| 7. RoE 52.15% |
| 8. Rev. Trend 74.84% |
| 9. EPS Trend 56.97% |
What is the price of ASML shares?
As of December 25, 2025, the stock is trading at EUR 899.00 with a total of 59,585 shares traded.
Over the past week, the price has changed by +2.86%, over one month by +4.68%, over three months by +11.46% and over the past year by +31.85%.
Over the past week, the price has changed by +2.86%, over one month by +4.68%, over three months by +11.46% and over the past year by +31.85%.
Is ASML a buy, sell or hold?
ASML Holding has no consensus analysts rating.
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1007.9 | 12.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1012.1 | 12.6% |
ASML Fundamental Data Overview December 22, 2025
Market Cap USD = 409.80b (349.95b EUR * 1.171 EUR.USD)
Market Cap EUR = 349.95b (349.95b EUR * 1.0 EUR.EUR)
P/E Trailing = 37.1794
P/E Forward = 34.0136
P/S = 10.8641
P/B = 18.4249
P/EG = 1.9951
Beta = 1.355
Revenue TTM = 32.21b EUR
EBIT TTM = 8.84b EUR
EBITDA TTM = 9.57b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.01b EUR (from shortTermDebt, last fiscal year)
Debt = 4.69b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -8.05b EUR (from netDebt column, last fiscal year)
Enterprise Value = 349.52b EUR (349.95b + Debt 4.69b - CCE 5.13b)
Interest Coverage Ratio = 57.50 (Ebit TTM 8.84b / Interest Expense TTM 153.7m)
FCF Yield = 2.56% (FCF TTM 8.94b / Enterprise Value 349.52b)
FCF Margin = 27.76% (FCF TTM 8.94b / Revenue TTM 32.21b)
Net Margin = 29.38% (Net Income TTM 9.46b / Revenue TTM 32.21b)
Gross Margin = 52.71% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 53.69%)
Tobins Q-Ratio = 7.75 (Enterprise Value 349.52b / Total Assets 45.10b)
Interest Expense / Debt = 3.28% (Interest Expense 153.7m / Debt 4.69b)
Taxrate = 17.77% (442.2m / 2.49b)
NOPAT = 7.27b (EBIT 8.84b * (1 - 17.77%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.25 (Debt 4.69b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.84 (Net Debt -8.05b / EBITDA 9.57b)
Debt / FCF = -0.90 (Net Debt -8.05b / FCF TTM 8.94b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.98% (Net Income 9.46b / Total Assets 45.10b)
RoE = 52.15% (Net Income TTM 9.46b / Total Stockholder Equity 18.15b)
RoCE = 42.38% (EBIT 8.84b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 87.42% (NOPAT 7.27b / Invested Capital 8.31b)
WACC = 7.54% (E(349.95b)/V(354.64b) * Re(7.60%) + D(4.69b)/V(354.64b) * Rd(3.28%) * (1-Tc(0.18)))
Discount Rate = 7.60% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.69%
[DCF Debug] Terminal Value 73.02% ; FCFE base≈6.50b ; Y1≈4.80b ; Y5≈2.78b
Fair Price DCF = 136.0 (DCF Value 52.80b / Shares Outstanding 388.1m; 5y FCF grow -30.84% → 3.0% )
EPS Correlation: 56.97 | EPS CAGR: 9.32% | SUE: 0.71 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.53 | Chg30d=-0.070 | Revisions Net=+1 | Analysts=10
EPS next Year (2026-12-31): EPS=25.91 | Chg30d=+0.031 | Revisions Net=+2 | Growth EPS=+4.8% | Growth Revenue=+5.7%
Market Cap EUR = 349.95b (349.95b EUR * 1.0 EUR.EUR)
P/E Trailing = 37.1794
P/E Forward = 34.0136
P/S = 10.8641
P/B = 18.4249
P/EG = 1.9951
Beta = 1.355
Revenue TTM = 32.21b EUR
EBIT TTM = 8.84b EUR
EBITDA TTM = 9.57b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.01b EUR (from shortTermDebt, last fiscal year)
Debt = 4.69b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -8.05b EUR (from netDebt column, last fiscal year)
Enterprise Value = 349.52b EUR (349.95b + Debt 4.69b - CCE 5.13b)
Interest Coverage Ratio = 57.50 (Ebit TTM 8.84b / Interest Expense TTM 153.7m)
FCF Yield = 2.56% (FCF TTM 8.94b / Enterprise Value 349.52b)
FCF Margin = 27.76% (FCF TTM 8.94b / Revenue TTM 32.21b)
Net Margin = 29.38% (Net Income TTM 9.46b / Revenue TTM 32.21b)
Gross Margin = 52.71% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 53.69%)
Tobins Q-Ratio = 7.75 (Enterprise Value 349.52b / Total Assets 45.10b)
Interest Expense / Debt = 3.28% (Interest Expense 153.7m / Debt 4.69b)
Taxrate = 17.77% (442.2m / 2.49b)
NOPAT = 7.27b (EBIT 8.84b * (1 - 17.77%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.25 (Debt 4.69b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.84 (Net Debt -8.05b / EBITDA 9.57b)
Debt / FCF = -0.90 (Net Debt -8.05b / FCF TTM 8.94b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.98% (Net Income 9.46b / Total Assets 45.10b)
RoE = 52.15% (Net Income TTM 9.46b / Total Stockholder Equity 18.15b)
RoCE = 42.38% (EBIT 8.84b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 87.42% (NOPAT 7.27b / Invested Capital 8.31b)
WACC = 7.54% (E(349.95b)/V(354.64b) * Re(7.60%) + D(4.69b)/V(354.64b) * Rd(3.28%) * (1-Tc(0.18)))
Discount Rate = 7.60% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.69%
[DCF Debug] Terminal Value 73.02% ; FCFE base≈6.50b ; Y1≈4.80b ; Y5≈2.78b
Fair Price DCF = 136.0 (DCF Value 52.80b / Shares Outstanding 388.1m; 5y FCF grow -30.84% → 3.0% )
EPS Correlation: 56.97 | EPS CAGR: 9.32% | SUE: 0.71 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.53 | Chg30d=-0.070 | Revisions Net=+1 | Analysts=10
EPS next Year (2026-12-31): EPS=25.91 | Chg30d=+0.031 | Revisions Net=+2 | Growth EPS=+4.8% | Growth Revenue=+5.7%